MIRAXIDINE-DF

spray for external use 0.05%

50 ml, 100 ml

Dispensing conditions: NO PRESCRIPTION 

Фарм.тобы: Antiseptics and disinfectants

THERAPEUTIC INDICATIONS:

  • antiseptic product in the form of a "spray", a radically new packaging makes the product more effective and easy to use;

  • as a therapeutic and prophylactic agent in various infections, for aseptic treatment and disinfection;

  • postoperative treatment of the wound surface;

  • convenient treatment of purulent wounds, burn surfaces, bacterial and fungal skin diseases and mucous membranes in dentistry, surgery, urology, obstetrics and gynecology;

  • individual prevention of bacterial, fungal diseases after visiting public places (swimming pools, saunas).

dwldDownload instructions for use

Composition

Composition per 1 ml of the product, in milliliters

0.2% solution:

  • active substance: Chlorhexidine bigluconate solution 20% - 0.01 ml;
  • excipient: Purified water.

0.5% solution:

  • active substance: Chlorhexidine bigluconate solution 20% - 0.25 ml;
  • excipient: Purified water.

1% solution:

  • active substance: Chlorhexidine bigluconate solution 20% - 0.05 ml;
  • excipient: Purified water.

Pharmaceutical form

0.2%, 0.5%, 1% spray for external use 50 ml and 100 ml.

Pharmacotherapeutic group

Dermatology. Antiseptics and disinfectants. Biguanides and amidines. Chlorhexidine.

ATC code  D08AC02

Indications

As a therapeutic and prophylactic agent in various infections, for aseptic treatment and disinfection.

  • 0.2% solution:

Prevention of sexually transmitted infections (not later than 2 hours after sexual intercourse) (chlamydia, ureaplasmosis, trichomoniasis, gonorrhea, syphilis, genital herpes); decontamination of the skin (abrasions, cracks); purulent wounds, infected burns, bacterial and fungal skin diseases and mucous membranes of the genitourinary organs, in dentistry (rinses and irrigation - gingivitis, stomatitis, aphthae, periodontitis, alveolitis), for treatment and sanitation of reproductive tract in gynecology during treatment and diagnostic procedures, for disinfection of removable dentures.

  • 0.5% solution:

Treatment of wounds and burn surfaces; treatment of infected abrasions, skin cracks and open mucous membranes. Sterilization of medical instruments at 70ºC; disinfection of working surfaces of devices (including thermometers) and equipment, thermal treatment of which is undesirable.

  • 1% solution:

Disinfection of thermometers, working surfaces of medical equipment and devices, thermal treatment of which is undesirable, treatment of the operating field and surgeon's hands before surgery, skin disinfection, treatment of postoperative and burn wounds.

Contraindications

  • predisposition to allergic reactions;
  • dermatitis;
  • individual intolerance to chlorhexidine.

Posology and method of administration

Topically, externally.

  • 0.2% solution:

Apply 5-10 ml of the solution to the affected surface of the skin or mucous membranes of the genitourinary organs, oral cavity for 1-3 minutes 2-3 times a day (on a swab or by irrigation). To prevent sexually transmitted diseases (the product is effective if used not later than 2 hours after sexual intercourse), inject the contents of the bottle with the nozzle into the urethra of men (2-3 ml), women (1-2 ml) and the vagina (5-10 ml) for 2-3 minutes. After the procedure it is recommended not to urinate for 2 hours. Treat the skin on the inner surfaces of the thighs, pubis, and genitals.

  • 0.5% solution:

Topically in the form of irrigations, rinses and applications - apply 5-10 ml of solution to the affected skin surface or mucous membranes with exposure for 1-3 minutes 2-3 times a day (on a swab or by irrigation).

Treatment of medical instruments and work surfaces is carried out with a clean sponge soaked in a solution of the product or by soaking.

  • 1% solution:

Before treating with antiseptic solution wash and wipe the surgeon's hands thoroughly with soap and water and rinse them thoroughly with antiseptic (20-30 ml). The skin of postoperative wounds is treated with a clean swab.

Treatment of medical instruments and work surfaces is carried out with a clean sponge soaked in a solution of the product or by soaking.

Adverse reactions

The adverse reactions below are listed according to their frequency of occurrence.

Very common:

  • stickiness of hands for 3-5 min.

Rare:

  • dry and itchy skin;
  • dermatitis;
  • teeth staining;
  • tartar deposition;
  • taste disorder (in the treatment of gingivitis).

Very rare:

  • allergic reactions (skin rash);
  • photosensitization.

Overdose

Symptoms: There is no evidence of product overdose.

Treatment: In case of accidental ingestion, Miraxidine-DF® is not absorbed, in this case it is necessary to wash the stomach with milk, raw egg, gelatin or plenty of water and take adsorbents (activated charcoal). If necessary, administer symptomatic therapy.

Use during pregnancy or breastfeeding

Use with caution to lactating mothers and pregnant women because of the risk of allergic reactions!

Pediatric population

Children and adolescents of 3 to 18 years of age should only use Miraxidine-DF® spray in the form of irrigations when treating skin, wounds and ulcers. In the treatment of diseases of the oral cavity apply with swabs.

Special warnings

In patients with open craniocerebral trauma, spinal cord injuries, tympanic membrane perforation should be avoided.

In case of contact with the mucous membrane of the eye, rinse quickly and thoroughly with water.

Presentation and package

50 ml or 100 ml of the product is poured into plastic bottles with a spray nozzle and a protective cap. One bottle is with instruction for use in the state and Russian language are placed in a carton pack.

Storage conditions

Store in a place protected from light, at a temperature below 25оС.

Keep out of the reach of children.

Shelf life

2 years

Manufacturer

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan, tel.: (727) 253-03-88.

Marketing authorization holder

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan.

Name, address, contact information of the organization accepting claims (proposals) against quality of products from consumers in the territory of the Republic of Kazakhstan, which is responsible for post-authorization safety surveillance of the medicine:

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan,

Tel./Fax: (727) 253-07-07, 253-03-88, e-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра.

Осы препаратқа сұрақ қою